Advanced Biomed Inc. Common Stock

ADVB | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.29

-$0.25 (-3.82%)

At close: Sep 21, 2026, 3:59 PM ET

$6.47

+$0.18 (+2.86%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.82%

(1D)

Rating

Updated: Aug 24, 2026

23.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $8.69M

1D Range

6.28 6.69

52W Range

3.61 24.23

Valuation (TTM)

PE -29.95

PB 0.94

EV/EBITDA -6.76

Valuation (NTM)

Forward PE N/A

Forward PEG 0.04

Price Target N/A

Cash Flow

FCF Yield -8.0%

SBC Adj. FCF Yield -8.0%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -30.7% | N/A

FCF 3Y | 5Y 21.0% | N/A

Returns

ROA -6.4%

ROE -20.7%

ROIC -11.0%

Financial Health

Net Cash

$1.93M

Current Ratio 7.38

Interest Coverage -9,783.79

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these ...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 31

IPO Date Mar 5, 2025

Website www.advanbiomed.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.